Orthopaedic Bioengineering Research Laboratory 2010-2011

Total Page:16

File Type:pdf, Size:1020Kb

Orthopaedic Bioengineering Research Laboratory 2010-2011 2010-2011 Report including the Orthopaedic Bioengineering Research Laboratory Preface It is my pleasure to present our 2010-2011 report been possible without a number of our donors from the Orthopaedic Research Center and the stepping up to provide supplemental funding. Orthopaedic Bioengineering Research Laboratory I’m particularly grateful to Mr. Jim Kennedy for at Colorado State University. Our principal focus providing supplemental operating funds and continues to be solving the significant problems in continuing the legacy of his mother, Barbara Cox equine musculoskeletal disease as can be seen in this Anthony. I’m also grateful to Abigail Kawananakoa report but we also continue to investigate questions for continued support over and above the Endowed relevant to human joint disease and techniques Chair she donated three years ago; and Herbert Allen and devices for human osteoarthritis and articular for continuing to provide considerable support for cartilage repair when the technique can also benefit investigation of cutting edge therapies. the horse. There have been a number of notable projects in this regard. The studies, led by Dr. Dave We have added an Equine Sports Medicine Frisbie at the ORC in partnership with Dr. Alan Ambulatory clinical arm to the Orthopaedic Research Grodzinsky at MIT on an NIH Program Grant in Center and also initiated two residencies in Sports cartilage repair, have been completed and results Medicine and Rehabilitation. This follows on from are still be analyzed. We have three other ongoing the accreditation of a new specialty college, the NIH grants in partnership with collaborators. One is American College of Veterinary Sports Medicine and with Dr. Connie Chu at the University of Pittsburgh Rehabilitation. Drs. Haussler, Frisbie and Kawcak, as looking at stem cells in fibrin/PRP and articular well as myself, are Foundation Diplomates and felt cartilage repair (Dr. Laurie Goodrich is the PI on the we had the appropriate ability and responsibility to sub-contract at CSU and other collaborators include train residents in this new specialty. Dr. Dora Ferris Dr. Lisa Fortier of Cornell University and Dr. Bob Sah is in her second year and Dr. Erin Contino is in her of the University of California, San Diego). This was a first year. I would like to extend special thanks to 12-month study that has been completed and results Gail Holmes for providing funding for the three year are still being analyzed with the other collaborators. program for Erin Contino. The work with Dr. Jude Samulski at the University of North Carolina on Dr. Laurie Goodrich’s NIH KO8 Accomplishments at the ORC over the past two grant on gene therapy (co-mentored by Drs. Samulski years are detailed in this report. Validation and and McIlwraith) is progressing well and we have clarification of the benefits of mesenchymal stem some exciting results with regard to long term protein therapy, platelet-rich plasma (PRP), as well as production with the AAV vector. The third NIH grant autologous conditioned serum (IRAP II) are all is with Dr. Steve Trippel at the University of Indiana in this report. These accomplishments could not in which Drs. Frisbie and McIlwraith are co-PIs on a be achieved without our team of faculty and staff sub-contract of an NIH grant involving gene therapy as well as the excellent support of equine funding and articular cartilage repair and the equine study agencies (Grayson-Jockey Club Research Foundation, will commence in the summer of 2012. American Quarter Horse Association, and United States Equestrian Federation), corporate funding, There have been some significant publications and individual donors. With this help we continue from the horse-human collaborative projects in to achieve our goals and also make new ones as new leading journals in the last two years. At the same clinical questions arise. time, many projects addressing equine specific problems have been completed and published and Best wishes, all of this is detailed in this report. We handled the challenges created by the economic recession well in the 2010-2011 period. This would not have Wayne McIlwraith 1 Table of Contents Preface ...............................................................................1 Program Goals ..........................................................49 Goals Accomplished 2010-2011 ......................49 Mission ..............................................................................4 Current Goals ....................................................50 Research Focuses of the Orthopaedic Research Goals ..........................................................50 Research Center ..............................................................6 Research Goals Achieved 2010-2011 .............50 Research Focuses at the Orthopaedic Future and Current Research at the ORC .............54 Bioengineering Research Laboratory .........................7 Research Techniques Available at the Musculoskeletal Research Program............................9 Orthopaedic Research Center ....................................57 School of Biomedical Engineering............................10 Research Techniques Available at the Orthopaedic Bioengineering Faculty .............................................................................11 Research Laboratory ....................................................59 College of Veterinary Medicine and Biomedical Sciences ............................................11 Scientific Publications and Presentations ...............60 College of Engineering ............................................20 Funded Research Projects ...........................................87 College of Applied Human Sciences ......................22 Revenue and Expense, FY10 to FY11 .......................92 College of Agricultural Sciences .............................22 College of Natural Sciences .....................................23 Honors and Awards ......................................................95 Affiliate Faculty .........................................................24 Editorial and Scientific Advisory Boards Collaborators .............................................................26 2010-2011 .......................................................................96 2010-2011 Post Doctoral Fellows ...........................33 2010-2011 Equine Sports Professional Associations 2010-2011 .......................97 Medicine Residencies ........................................34 Advisory Board 2011 ...................................................99 2010-2011 Ph.D. Graduate Students ......................35 2010-2011 M.S. Graduate Students ........................37 Our Donors ..................................................................100 Research Scientist .....................................................38 Summary of Research Projects 2010-2011 ............105 Research Associates ..................................................38 Research Coordinator ..............................................41 Focus 1. Musculoskeletal Tissue Healing Administrative Staff ..................................................41 Consensus on Equine Tendon Disease: Director Gait Analysis Center/ Building on the 2007 Havemeyer ORC Staff Veterinarian .......................................41 Symposium ........................................................106 Equine Bone Marrow-Derived Stem Cells: Orthopaedic Research Program ................................42 Comparing the Ilium and the Sternum .........109 Areas of Expertise of Personnel ..............................42 Equine Mesenchymal Stem Cells in Vitro Student Hourly Assistants at the ORC 2010-2011 .43 Differentiation Capacity: Differences Between Sternum and Ilium ............................111 Volunteers at the ORC 2010-2011 .............................43 Equine Models of Articular Cartilage Repair .....113 Graduate Students – Placement Since Inception ...44 Evaluation of Intra-Articular Mesenchymal Stem Cells to Augment Healing of Surgery Residents Supervised (and Outcome) ......46 Microfractured Chondral Defects ..................116 Program Synopsis .........................................................47 Expansion of Adult Equine Bone Marrow History ........................................................................47 Mesenchymal Stem Cells on Fibrinogen- Research Activities ...................................................47 Rich Protein Surfaces Derived From Impact ........................................................................48 Blood Plasma .....................................................119 Program Trends ........................................................48 2 Table of Contents Continued Focus 2. Early Diagnosis of Bone and Joint Disease Focus 4. Continued Development of Novel Incidence of Radiographic Changes in Young Therapies for Traumatic Synovitis, Capsulitis, Cutting Horses ...................................................122 and Osteoarthritis in the Horse A Descriptive Study of the Equine Proximal Effects of Platelet-Rich Plasma Composition on Interphalangeal Joint Using Magnetic Anabolic and Catabolic Activities in Equine Resonance Imaging, Contrast Arthrography, Cartilage and Meniscal Explants.....................153 and Arthroscopy ...............................................125 Gene Therapy Approach to Treat Osteoarthritis The Relationship Between Radiographic Using AAVIRAP................................................157 Changes and Performance Outcomes in Influences
Recommended publications
  • Altmetric.Com and Plumx
    This is a preprint of an article published in Scientometrics. The final authenticated version is available online at: https://doi.org/10.1007/s11192-021-03941-y A large-scale comparison of coverage and mentions captured by the two altmetric aggregators- Altmetric.com and PlumX Mousumi Karmakara, Sumit Kumar Banshalb, Vivek Kumar Singha,1 1Department of Computer Science, Banaras Hindu University, Varanasi-221005, India 2Department of Computer Science, South Asian University, New Delhi-110021, India. Abstract: The increased social media attention to scholarly articles has resulted in creation of platforms & services to track the social media transactions around them. Altmetric.com and PlumX are two such popular altmetric aggregators. Scholarly articles get mentions in different social platforms (such as Twitter, Blog, Facebook) and academic social networks (such as Mendeley, Academia and ResearchGate). The aggregators track activity and events in social media and academic social networks and provide the coverage and transaction data to researchers for various purposes. Some previous studies have compared different altmetric aggregators and found differences in the coverage and mentions captured by them. This paper attempts to revisit the question by doing a large-scale analysis of altmetric mentions captured by the two aggregators, for a set 1,785,149 publication records from Web of Science. Results obtained show that PlumX tracks more altmetric sources and captures altmetric events for a larger number of articles as compared to Altmetric.com. However, the coverage and average mentions of the two aggregators, for the same set of articles, vary across different platforms, with Altmetric.com recording higher mentions in Twitter and Blog, and PlumX recording higher mentions in Facebook and Mendeley.
    [Show full text]
  • RELX Group Annual Reports and Financial Statements 2015
    Annual Reports and Financial Statements 2015 Annual Reports and Financial Statements 2015 RELX Group is a world-leading provider of information and analytics for professional and business customers across industries. We help scientists make new discoveries, lawyers win cases, doctors save lives and insurance companies offer customers lower prices. We save taxpayers and consumers money by preventing fraud and help executives forge commercial relationships with their clients. In short, we enable our customers to make better decisions, get better results and be more productive. RELX PLC is a London listed holding company which owns 52.9 percent of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1 percent of RELX Group. Forward-looking statements The Reports and Financial Statements 2015 contain forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those currently being anticipated. The terms “estimate”, “project”, “plan”, “intend”, “expect”, “should be”, “will be”, “believe”, “trends” and similar expressions identify forward-looking statements. Factors which may cause future outcomes to differ from those foreseen in forward-looking statements include, but are not limited to competitive factors in the industries in which the Group operates; demand for the Group’s products and services; exchange rate fluctuations; general economic and business conditions; legislative, fiscal, tax and regulatory developments and political risks; the availability of third-party content and data; breaches of our data security systems and interruptions in our information technology systems; changes in law and legal interpretations affecting the Group’s intellectual property rights and other risks referenced from time to time in the filings of the Group with the US Securities and Exchange Commission.
    [Show full text]
  • Orthopaedics & Traumatology: Surgery & Research
    Author guidelines Orthopaedics & Traumatology: Surgery & Research Revue de Chirurgie Orthopédique et Traumatologique Orthopaedics & Traumatology: Surgery & Research (OTSR) and its French version Revue de Chirurgie Orthopédique et Traumatologique (RCOT) publish original scientific works in English and French related to orthopaedics from all domains. All the original articles, systematic reviews, meta-analysis, review articles, technical notes, concise follow-up of a former OTSR study are published in English and French (OTSR-RCOT does not publish Case reports): in English (OTSR) in electronic form only and in French (RCOT) in paper and electronic editions. Only the English version (OTSR) is indexed in international databases. Original articles must not have been published elsewhere or be simultaneously submitted for publication in another journal. The journal agrees to use the “Uniform Requirements for manuscripts submitted to biomedical journals” (www.icjme.org). It also adheres to the rules developed by the Committee on Publication Ethics (COPE) and the recommendations of the French National Authority for Health (HAS). Authors must submit an electronic version only of the article using the journal’s online submission site: https://www.editorialmanager.com/otsr/. French-speaking authors should submit in French. Non-French-speaking authors can submit in either French or English. All articles accepted and submitted in French will be translated from French to English by the Editorial Board. Manuscripts submitted in English will not be translated into French. When the original article is submitted in English, the corresponding French version in RCOT contains only the title (in French and English), the abstract in French or English, and the reference needed to access the full-text article.
    [Show full text]
  • The Mipim Awards 2016 Finalists
    15 to 18 March 2016 - Palais des Festivals, Cannes Press release THE MIPIM AWARDS 2016 FINALISTS Paris, 28 January, 2016 - The eleven members of the international jury for the MIPIM Awards 2016 have released the list of the 44 finalists for this prestigious competition. Organised by Reed MIDEM, a subsidiary of Reed Exhibitions, MIPIM will take place in Cannes from March 15-18, 2016. This year, 230 projects from 42 countries have been submitted to one of the 11 categories of the MIPIM Awards. 2016 features a new category – ‘the Best Healthcare development' - which focusses on the fast-growing healthcare property segment. "The projects were carefully examined by the jury which represents the whole scope of the real estate industry. I found it particularly encouraging to see the growing number of projects in the residential category, including social housing and forward-thinking concepts. Also, the new category Best Healthcare Development is in tune with the need of healthcare facilities in an aging European society," said the President of the Jury, Barbara Knoflach, Deputy Chief Executive & Global Head of Investment Management at BNP Paribas Real Estate. The winners will be selected by both attendees voting in Cannes for projects of their choice and the jury. The jury’s decision will count for 50% of the vote as will the attendees’ share. For the fifth year in a row, the "People’s Choice Award” will reward the project that won the most votes online in the run-up to MIPIM. The public will soon be able to vote for this category on the MIPIM website and the show’s official Facebook page.
    [Show full text]
  • Design of a Serotonin 4 Receptor Radiotracer with Decreased Lipophilicity for Single Photon Emission Computed Tomography
    European Journal of Medicinal Chemistry 94 (2015) 386e396 Contents lists available at ScienceDirect European Journal of Medicinal Chemistry journal homepage: http://www.elsevier.com/locate/ejmech Original article Design of a serotonin 4 receptor radiotracer with decreased lipophilicity for single photon emission computed tomography Nathalie Fresneau a,Noe Dumas b, Benjamin B. Tournier b, Christine Fossey c, Celine Ballandonne c,Aurelien Lesnard c, Philippe Millet b, Yves Charnay b, * * Thomas Cailly c, Jean-Philippe Bouillon a, ,Fred eric Fabis c, a Normandie Univ., COBRA, UMR 6014 et FR 3038, Univ. Rouen, INSA Rouen, CNRS, 1 Rue Tesniere, F-76821 Mont-Saint-Aignan Cedex, France b Hopitaux^ Universitaires de Geneve, Departement de Sante Mentale et de Psychiatrie, Service de Psychiatrie Generale, Unite des Biomarqueurs de Vulnerabilite, Chemin du Petit-Bel-Air, 2, CH-1225 Geneve, Switzerland c Normandie Univ., Universite de Caen Basse-Normandie, CERMN (EA 4258, FR CNRS 3038 INC3M, SF 4206 ICORE), UFR des Sciences Pharmaceutiques, Bd Becquerel, F-14032 Caen, France article info abstract Article history: With the aim to develop a suitable radiotracer for the brain imaging of the serotonin 4 receptor subtype Received 3 June 2014 (5-HT4R) using single photon emission computed tomography (SPECT), we synthesized and evaluated a Received in revised form library of di- and triazaphenanthridines with lipophilicity values which were in the range expected to 5 March 2015 favour brain penetration, and which demonstrated specific binding to the target of interest. Adding Accepted 6 March 2015 additional nitrogen atoms to previously described phenanthridine ligands exhibiting a high unspecific Available online 9 March 2015 binding, we were able to design a radioiodinated compound [125I]14.
    [Show full text]
  • Elsevier S&T Books -- Manuscript Preparation Guidelines
    1 Elsevier S&T Books • Manuscript Preparation Guidelines This document includes general guidelines designed to help you meet Elsevier’s manuscript requirements, reducing queries and saving your time during the copyediting, typesetting and proofing of your book. If you have any queries or concerns in relation to these guidelines, please contact your Editorial Project Manager (EPM), who will be able to provide assistance. Your EPM will be in frequent contact as you write your manuscript – please follow the delivery schedule as outlined in your contract and let your EPM know immediately if you are unsure about or envisage any delay in your delivery schedule. 1. Who’s Who: The People Working On Your Elsevier Book ............................................................................................ 2 2. The Basics of Formatting Your Manuscript ............................................................................................................... 3 3. Text Formatting and Copyediting Guidelines .............................................................................................................. 5 4. Artwork and Table Guidelines .................................................................................................................................... 8 5. Abstracts and Keywords ......................................................................................................................................... 10 6. Additional Deliverables ..........................................................................................................................................
    [Show full text]
  • Form 20-F Annual Report 2006 on Form 20-F Annual Report 2006 on Form 20-F
    169724 20-F Cover_v2.qxd 7/3/07 16:00 Page 1 > www.reedelsevier.com Reed Elsevier Form 20-F Annual Report 2006 on Form 20-F Annual Report 2006 on Form 20-F Annual Report 2006 on Form As filed with the Securities and Exchange Commission on March 22, 2007 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) n REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Or ¥ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2006 Or n TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Or n SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 1-3334 REED ELSEVIER PLC REED ELSEVIER NV (Exact name of Registrant as specified in its charter) (Exact name of Registrant as specified in its charter) England The Netherlands (Jurisdiction of incorporation or organisation) (Jurisdiction of incorporation or organisation) 1-3 Strand Radarweg 29 London WC2N 5JR 1043 NX Amsterdam England The Netherlands (Address of principal executive offices) (Address of principal executive offices) Securities registered or to be registered pursuant to Section 12(b) of the Act: Name of exchange on which Title of each class registered Reed Elsevier PLC: American Depositary Shares (each representing four Reed Elsevier PLC ordinary shares) New York Stock Exchange Ordinary shares of 12.5p each (the ""Reed Elsevier PLC ordinary shares'') New York Stock Exchange* Reed Elsevier NV: American Depositary Shares (each representing two Reed Elsevier NV ordinary shares) New York Stock Exchange Ordinary shares of 40.06 each (the ""Reed Elsevier NV ordinary shares'') New York Stock Exchange* * Listed, not for trading, but only in connection with the listing of the applicable Registrant's American Depositary Shares issued in respect thereof.
    [Show full text]
  • Science and Medical Publishers Imprints List Version 1.1, October 2007 8 October 2007 Version
    Science and Medical Publishers Imprints List Version 1.1, October 2007 8 October 2007 version Publishing house Imprints & former imprints Internet site or e-mail address for permissions contacts or information American Association AAAS http://www.sciencemag.org/help/readers/per for the Advancement of Science (magazine) missions.dtl Science American Chemical ACS http://pubs.acs.org/copyright/index.html Society Chemical Abstracts Service CAS American Institute of AIP http://journals.aip.org/copyright.html Physics [include AIP member societies?] [email protected] American Medical AMA http://pubs.ama- Association assn.org/misc/permissions.dtl American Physical APS http://librarians.aps.org/permissionscopy.htm Society l American Psychological APA http://www.apa.org/about/copyright.html Association American Society of ASCE http://www.pubs.asce.org/authors/Rightslink Civil Engineers WelcomePage.htm American Society of ASCO http://jco.ascopubs.org/misc/permissions.sht Clinical Oncology ml Association of ACM http://www.acm.org/pubs/copyright_policy/ Computing Machinery, Inc. Atlas Medical Clinical Publishing http://www.clinicalpublishing.co.uk/contact. Publishing Ltd asp BMJ Publishing Group British Medical Journal http://journals.bmj.com/misc/permissions.dtl BMJ Brill Academic Brill http://www.brill.nl/default.aspx?partid=15 Publishers Hotei Publishing IDC Martinus Nijhoff VSP Cambridge University CUP Press CABI CSIRO Publishing CSIRO http://www.publish.csiro.au/nid/182.htm#8 Commonwealth Scientific and Industrial Research Organisation (Australia)
    [Show full text]
  • List of CLASS Publisher Members (April 2019) PUBLISHERS
    List of CLASS Publisher members (April 2019) PUBLISHERS Name of Member Imprints Grant of right of Communication permitted All Publications by Alkem (Alkem Kids Read Alkem Alkem Quality Edition (AQE)) Armour Publishing Pte Ltd. Armour Armour Education Genesis Genesis for Kids Little Knights Arts Publishing (Ho Lye Kim) All Publications by Arts Publishing Asian Media Information and All Publications by AMIC Communication Centre (AMIC) AsiaPac Books Pte. Ltd Asiapac Books Asiapac Culture Asiapac Comic Cambridge University Press Cambridge University Press Cambridge Archive Editions Foundation Books Cambridge-Hitachi Global Grid for Learning Hotmaths Cambridge-Wellesley Press Cambridge-English 360 Georgian Press Cannon International (Tan Wu Cheng) Cannon International Kingsway Publishers CCH Asia Pte. Ltd Wolters Kluwer Cengage Learning Asia Pte Ltd AutoDesk Press Brooks/Cole Charles Scribner's & Sons Christian Large Print Cengage Learning Cengage Learning Australia Cengage Learning EMEA Concept Media Course Technology Delmar Learning Five Star Gale Gale Asia Graham & Whiteside CLASS LTD SCHEDULE APR 2019 1 OF 14 Name of Member Imprints Grant of right of Communication permitted Greenhaven Press (eBooks only) KidHaven Press (eBooks only) Heinle Large Print Press Cengage Learning Asia Pte Ltd Lucent Books (eBooks only) Macmillan Reference USA Milady National Geographic Learning Nelson Australia Nelson Education Primary Source Media Schirmer South-Western College St. James Press Thorndike Press Twayne Publishers U.X.L. Wadsworth ASTD/ATD Press Mercury Learning and Information Editions Didier Millet Pte. Ltd. Editions Didier Millet The Chic Collections Educational Publishing House All Publications by Educational Pte. Ltd Publishing House Pte. Ltd United Publishing House Pte. Ltd (dissolved in 1997 Incorporated in 1957) Elm Tree Distributors Pte.
    [Show full text]
  • Chondroitin Sulfate Safety and Quality
    molecules Review Chondroitin Sulfate Safety and Quality Nicola Volpi Department of Life Sciences, Laboratory of Biochemistry and Glycobiology, University of Modena and Reggio Emilia, 41125 Modena, Italy; [email protected]; Tel.: +39-59-2055543; Fax: +39-59-2055548 Academic Editor: Cédric Delattre Received: 7 March 2019; Accepted: 9 April 2019; Published: 12 April 2019 Abstract: The industrial production of chondroitin sulfate (CS) uses animal tissue sources as raw material derived from different terrestrial or marine species of animals. CS possesses a heterogeneous structure and physical-chemical profile in different species and tissues, responsible for the various and more specialized functions of these macromolecules. Moreover, mixes of different animal tissues and sources are possible, producing a CS final product having varied characteristics and not well identified profile, influencing oral absorption and activity. Finally, different extraction and purification processes may introduce further modifications of the CS structural characteristics and properties and may lead to extracts having a variable grade of purity, limited biological effects, presence of contaminants causing problems of safety and reproducibility along with not surely identified origin. These aspects pose a serious problem for the final consumers of the pharmaceutical or nutraceutical products mainly related to the traceability of CS and to the declaration of the real origin of the active ingredient and its content. In this review, specific, sensitive and validated analytical
    [Show full text]
  • Current Research in Translational Medicine Guide for Authors
    Current Research in Translational Medicine Guide for authors Current Research in Translational Medicine, previously named Translational Medicine at the following address: Pathologie Biologie, is an online quarterly publication dedicated to http://ees.elsevier.com/retram/default.asp hematology, immunology, infectiology, hematopoietic cell transplantation, and cellular and gene therapy. • then click on « register » in the middle of the top navigation bar and fill in the requested information : first name, last name, email. The journal publishes English-language editorials, original articles, You will receive an email confirmation with your username and reviews, and short reports including case-reports. Contributions are your password. intended to draw attention to experimental medicine and • You only need to register once, the first time you use the EES. translational research. Current Research in Translational Medicine Once you are registered, you simply log in each time you want to periodically publishes thematic issues and is indexed in all major use the EES. international databases. • Once you have logged in, you will brought to the Author Main Menu where you can start with Submit New Manuscript. Follow Core areas covered in Current Research in Translational Medicine the instructions to upload your documents. are: • IMPORTANT ! Different files are necessary for: ° The title page: title of the article ; authors; complete address • Hematology and phone number. (This separated file containing the title • Immunology page allows in particular to protect the anonymity of the • Infectiology authors by excluding it from the sending for review of the manuscript.) • Hematopoietic Cell Transplantation ° The manuscript: summary keywords; text; bibliographical • Cellular and Gene Therapy references; tables and legends of tables; legends of figures.
    [Show full text]
  • GRAS Notice 666, Chondroitin Sodium Sulfate
    ORIGINAL SUBMISSION AM IN T ALATI & UPADHYE ATTO R NEYS AT LAW GRN oootot,6 As hish R. Talati 312.327.3381 Tel Ashish@A minTalati. com 312.884 .735 2 Fax A ugust 16, 20 I 6 Office of Food Add iti ve Safe ty (H FS-200) Cente r fo r Food a fety and Applied utrition Food A nd Drug Adm in istration 500 1 Campus Drive College Park, MD 20740-3835 Rc: Gener ally Rec~ed As Safe ("GRAS") Notification for Chondroitin Sodium Sulfa te Dear S ir/Madam : Pursuant to proposed 2 I CFR 170 .36, o ur clie nt, Gnosis S .p.A. (" Gnosis"), thro ugh Amin Talati & Upadhye, LLC as its attorneys, here by provides notice ofa claim that the food ingredi ent cho ndroitin sulfate sodium, described in the enclosed notification document, is exempt from the premarket approval requirement of the Federal Food, D ru g, and Cosme tic Act because it has been determined to be Generally Recognized As Safe (GRAS), based on scientific proced ures. As required, pl ease find encl osed three co pi es ofthe notification. Please do not hesitate to contact me at Ashish@ A minTalati.com or 312-327-338 1 if you have any questions or require addi tional info rmation. S incerely, (b) (6) ~~CG~D '¥~[Q) AUG 1 7 2016 OFFICE OF FOOD ADDITIVE SAFETY Amin Talat i & Upadhye, LLC • 100 South Wacker D rive, Su ite 2000 • Chicago, IL 60606 · Office (3 12) 466- 1033 • Fax (3 12) 884- 7352 • www.AminTalati.com GRAS NOTIFICATION I.
    [Show full text]